Inflammation-induced IgA+ Cells Dismantle Anti-liver Cancer Immunity
Authors
Affiliations
The role of adaptive immunity in early cancer development is controversial. Here we show that chronic inflammation and fibrosis in humans and mice with non-alcoholic fatty liver disease is accompanied by accumulation of liver-resident immunoglobulin-A-producing (IgA) cells. These cells also express programmed death ligand 1 (PD-L1) and interleukin-10, and directly suppress liver cytotoxic CD8 T lymphocytes, which prevent emergence of hepatocellular carcinoma and express a limited repertoire of T-cell receptors against tumour-associated antigens. Whereas CD8 T-cell ablation accelerates hepatocellular carcinoma, genetic or pharmacological interference with IgA cell generation attenuates liver carcinogenesis and induces cytotoxic T-lymphocyte-mediated regression of established hepatocellular carcinoma. These findings establish the importance of inflammation-induced suppression of cytotoxic CD8 T-lymphocyte activation as a tumour-promoting mechanism.
Global research prospects and trends in TFH cells and tumors: a bibliometric analysis.
Lei H, Hu J, Zhu J, Li R, Zhao Y, Zhao Y Front Oncol. 2025; 15:1443890.
PMID: 40027134 PMC: 11867951. DOI: 10.3389/fonc.2025.1443890.
POU2F2 B cells enhance antitumor immunity and predict better survival in non small cell lung cancer.
Shi H, Wang W, Luo J, Song G, Han R Sci Rep. 2025; 15(1):6549.
PMID: 39994401 PMC: 11850725. DOI: 10.1038/s41598-025-90817-3.
MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation.
Armstrong D, Chang C, Hong M, Green L, Shen Y, Hudson W Sci Adv. 2025; 11(7):eads4227.
PMID: 39937892 PMC: 11817953. DOI: 10.1126/sciadv.ads4227.
Sivakumar S, Jainarayanan A, Arbe-Barnes E, Sharma P, Ni Leathlobhair M, Amin S Nat Commun. 2025; 16(1):1397.
PMID: 39915477 PMC: 11802853. DOI: 10.1038/s41467-024-55424-2.
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy.
Song S, Wang C, Chen Y, Zhou X, Han Y, Zhang H Cancer Immunol Immunother. 2025; 74(3):92.
PMID: 39891668 PMC: 11787113. DOI: 10.1007/s00262-024-03936-7.